Jammu, Apr 25 (Reporter) To mark a new era in affordable, precision-driven cancer care for patients across India, the All-India Institute of Medical Sciences (AIIMS) Jammu on Friday announced the initiation of laboratory operations at the newly inaugurated state-of-the-art “Centre for Advanced Genomics and Precision Medicine”. As per the official communiqué, the Centre was inaugurated by Executive Director and CEO, AIIMS Jammu Prof. (Dr.) Shakti Kumar Gupta along with Dean Research and Medical Superintendent Lt Gen Dr Sunil Kant, Dean (Academics) Prof Dr Meeta Gupta; Associate Dean (Research) Prof Dr. Shabab L Angurana, Registrar Shailender Slathia; Dr Poonam Sharma, Head, Department of Pathology; and Dr Sudarshan, Vice President - Global Operations at 4baseCare. The Centre, established in collaboration with 4baseCare, is equipped with cutting-edge Next Generation Sequencing (NGS) technology, read the handout. It further said that the facility enables comprehensive genomic profiling for cancer patients, allowing clinicians to design highly targeted, individualized treatment plans, adding, “by integrating genomic data with AI-driven diagnostics, the Centre aims to enhance early disease detection, optimize therapy selection, and minimize ineffective treatments, thereby improving patient outcomes and quality of life.” “At AIIMS Jammu, the same high-quality NGS tests will now be available at very affordable prices making precision oncology accessible to a much broader segment of the population. This initiative is a significant step towards democratizing access to world-class cancer diagnostics and treatment in India,” it read. Executive Director and CEO, AIIMS Jammu, Prof. (Dr.) Shakti Kumar Gupta, stated, “For every patient we treat, we are treating a mother, a father, a sister, or a brother. This partnership is our promise to every family who walks through our doors that we will do everything in our power to bring them the care they deserve.” With the launch of this Centre, AIIMS Jammu cements its position as a frontrunner in India’s medical research landscape, he said and added, “the facility is poised to play a pivotal role in advancing precision oncology, rare disease diagnostics, reproductive medicine, and public health genomics, integrating these services into the broader public healthcare system...////...